Tocilizumab for giant cell arteritis: successful treatment with the occurrence of autoimmune thyreoiditis

被引：0
|
作者：
Jaspers, C. [1 ]
Reinbold, W. [2 ]
Turkiewicz, R. [3 ]
Lakomek, H. [4 ]
机构：
[1] Johannes Wesling Klinikum Minden, Klin Rheumatol & Endokrinol, Minden, Germany
[2] Johannes Wesling Klinikum Minden, Inst Radiol Nukl Med, Minden, Germany
[3] Johannes Wesling Klinikum Minden, Klin Pneumol, Minden, Germany
[4] Johannes Wesling Klinikum Minden, Klin Rheumatol & Geriatrie, Minden, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [41] Autoimmune Aspects of Giant Cell Arteritis
    Nesher, Gideon
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (07): : 454 - 455
  • [42] Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
    Unizony, S.
    Arias-Urdaneta, L.
    Miloslavsky, E.
    Arvikar, S.
    Khosroshahi, A.
    Keroack, B.
    Stone, J. R.
    Stone, J. H.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (11) : 1720 - 1729
  • [43] Tocilizumab and glucocorticoids for giant cell arteritis: the learning curve
    Mackie, Sarah L.
    Bhogal, Rayna
    LANCET RHEUMATOLOGY, 2023, 5 (12): : e703 - e705
  • [44] Trial of Tocilizumab in Giant-Cell Arteritis REPLY
    Stone, John H.
    Klearman, Micki
    Collinson, Neil
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15): : 1494 - 1495
  • [45] Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits
    Buttgereit, Frank
    Palmowski, Andriko
    Esen, Idil
    Brouwer, Elisabeth
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (04) : 489 - 492
  • [46] EFFICACY OF TOCILIZUMAB IN 31 PATIENTS WITH GIANT CELL ARTERITIS
    Dominguez-Casas, L. C.
    Loricera, J.
    Hernandez, J. L.
    Castaneda, S.
    Mera, A.
    Perez-Pampin, E.
    Peiro, E.
    Humbria, A.
    Calvo-Alen, J.
    Aurrecoechea, E.
    Narvaez, J.
    Sanchez-Andrade, A.
    Vela, P.
    Diez, E.
    Mariano, C.
    Lluch, P.
    Moll, C.
    Hernandez, I.
    Calvo-Rio, V.
    Ivorra, J.
    Corrales, A.
    Ortiz-Sanjuan, F.
    Gonzalez-Vela, C.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 614 - 614
  • [47] Comment on: Benchmarking tocilizumab use for giant cell arteritis
    Janagan, Shalini
    Guly, Catherine
    Skeoch, Sarah
    Robson, Joanna C.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [48] Successful Tocilizumab Treatment in a Child With Refractory Takayasu Arteritis
    Bravo Mancheno, Beatriz
    Perin, Francesca
    Rodriguez Vazquez del Rey, Maria del Mar
    Garcia Sanchez, Antonio
    Alcazar Romero, Pedro Pablo
    PEDIATRICS, 2012, 130 (06) : E1720 - E1724
  • [49] Serum Proteomics in Giant Cell Arteritis: Findings of the Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab Trial (The GUSTO Trial)
    Christ, Lisa
    Gloor, Andrea
    Kollert, Florian
    Gaber, Timo
    Buttgereit, Frank
    Reichenbach, Stephan
    Villiger, Peter
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 938 - 940
  • [50] Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis
    Reichenbach, Stephan
    Adler, Sabine
    Bonel, Harald
    Cullmann, Jennifer L.
    Kuchen, Stefan
    Butikofer, Lukas
    Seitz, Michael
    Villiger, Peter M.
    RHEUMATOLOGY, 2018, 57 (06) : 982 - 986
12345